August 2021
-
08.13.2021 Medicines Pfizer Expands Voluntary Nationwide Recall to include Four Additional Lots of CHANTIX® (varenicline) Tablets Due to N-Nitroso Varenicline Content -
08.13.2021 Medicines Pfizer Expands Voluntary Nationwide Recall to include Four Additional Lots of CHANTIX® (varenicline) Tablets Due to N-Nitroso Varenicline Content
July 2021
-
07.28.2021 Research Vaccines Pfizer and BioNTech Share Detailed Update to the Results from 6 Month Safety and Efficacy Data Analysis of Landmark COVID-19 Vaccine Study -
07.16.2021 Covid-19 Vaccines U.S. FDA Grants Priority Review for the Biologics License Application for Pfizer-BioNTech COVID-19 Vaccine -
07.16.2021 Medicines Pfizer Issues A Voluntary Nationwide Recall for Twelve Lots of CHANTIX® (varenicline) Tablets Due to N-Nitroso Varenicline Content -
07.08.2021 Vaccines Newly Published Expert Opinion Article Details Evidence for Classifying Aging Immune System as a High-Risk Condition for Pneumococcal Vaccine Policy -
07.08.2021 Vaccines Pfizer and BioNTech Provide Update on Booster Program in Light of the Delta-Variant
June 2021
-
06.11.2021 Medicines XELJANZ® Safety Review Recommendation Issued in the European Union
May 2021
-
05.28.2021 Responsibility Pfizer Colleagues to Mentor Veterans in Transition to Civilian Life -
05.11.2021 Research Pfizer’s Novel Prediction Model, Derived from Machine Learning, Shows Robust Performance for Identifying Heart Failure Patients At-Risk for Wild-Type Transthyretin Amyloid Cardiomyopathy, a Rare and Life-Threatening Condition -
05.04.2021 Medicines Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate -
05.04.2021 Medicines Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling